Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Chinese Patent Office
Johnson and Johnson
Citi
UBS
QuintilesIMS
US Army
Farmers Insurance

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086028

« Back to Dashboard

NDA 086028 describes CHLOROTHIAZIDE, which is a drug marketed by Abc Holding, Hikma Intl Pharms, Lederle, Mylan, Sandoz, Watson Labs, Hikma Pharms, Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, and Sun Pharma Global, and is included in twenty-three NDAs. It is available from two suppliers. Additional details are available on the CHLOROTHIAZIDE profile page.

The generic ingredient in CHLOROTHIAZIDE is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Summary for 086028
Tradename:CHLOROTHIAZIDE
Applicant:Hikma Intl Pharms
Ingredient:chlorothiazide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 086028
Ingredient-typeThiazides
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for 086028
Suppliers and Packaging for NDA: 086028
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 086028 ANDA West-ward Pharmaceutical Corp 0143-1209 N 0143-1209-01
CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 086028 ANDA West-ward Pharmaceutical Corp 0143-1209 N 0143-1209-10

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Jul 14, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Queensland Health
Citi
Federal Trade Commission
Fish and Richardson
Baxter
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.